Your session is about to expire
← Back to Search
REGN5715 for Allergy or Hay Fever
Study Summary
This trialtests if anti-birch allergy antibodies reduce symptoms of allergic reaction to birch pollen.
- Allergy (or Hay Fever)
- Pink Eye
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there long-term repercussions to using REGN5713-5714-5715?
"REGN5713-5714-5715 has yet to be proven effective in clinical trials, however, there is some safety data supporting its use. Consequently, our team scored it a 2."
Are people with the required qualifications able to sign up for this experiment currently?
"The study, which was published on clinicaltrials.gov on 8/15/2022 is still recruiting participants. The last edit to the posting was made on 10/13/2022."
How many individuals are being added to this clinical trial?
"The data available on clinicaltrials.gov supports that this study is open for recruitment and actively looking for participants. This trial was first posted on August 15th, 2020 and was last edited on October 13th, 2020. The study needs to recruit 300 patients from 2 sites in order to continue."
Share this study with friends
Copy Link
Messenger